TransMedics Group, Inc. (TMDX) has a market capitalization of $3.97B and trades at $115.68. The 52-week range is 62.23-156.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 20.7, Earnings Per Share (EPS) of $5.60, annual revenue of $605.49M.
The stock has a beta of 2.08, operates in the Healthcare sector.
